Clinical Trials Browser

Phase 3 × maribavir × 90 days × Clear all

NCT07511127 2026-04-06

Comparing the Efficacy of Different Durations of Maribavir Treatment Regimens in Allo-HSCT

Phase 3 Recruiting

Other hematologic neoplasm

Hematologic Neoplasms